048530.KQ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 liep. 2024 @ 08:35):
Our systems believe the stock currently is overvalued by -0.17% compare to its pairs and should correct downwards.

iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs...

Stats
Dzisiejszy wolumen	104 598
Średni wolumen	129 125
Kapitalizacja rynkowa	209.44B
EPS	KRW-11.66 ( Q1 \| 2024-03-31 )
Następna data zysków	( KRW0 ) 2024-08-09
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0 (Sector) 0 (Industry) 0
ATR14	KRW8.68 (0.14%)

Korelacja (AI algo v.1.1b): Overvalued: -0.17% KRW6 311.00 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: -0.09 (neutral)

Krótki: 0.02 (neutral)

Signal:(58.018) Neutral

iNtRON Biotechnology, Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

iNtRON Biotechnology, Korelacja - Waluta/Towar

0.06
( neutral )

0.14
( neutral )

0.16
( neutral )

-0.16
( neutral )

0.03
( neutral )

0.24
( neutral )

iNtRON Biotechnology, Finanse

Annual	2023
Przychody:	KRW9.59B
Zysk brutto:	KRW4.56B (47.58 %)
EPS:	KRW-292.11

FY	2023
Przychody:	KRW9.59B
Zysk brutto:	KRW4.56B (47.58 %)
EPS:	KRW-292.11

FY	2022
Przychody:	KRW14.01B
Zysk brutto:	KRW8.45B (60.36 %)
EPS:	KRW168.38

Financial Reports:

No articles found.

iNtRON Biotechnology, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

iNtRON Biotechnology,

iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.